Efficacy of single-dose oral ivermectin in treatment of rosacea in relation to demodex mites

Author:

Sharara Manal A.1,Abdel Hamid Kariman S.2,Imam Adel A.1

Affiliation:

1. MD, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

2. MBBCH, Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Abstract

Background Rosacea is a common chronic inflammatory cutaneous disease. Demodex mites play an important role in the etiology and pathogenesis of rosacea. Despite the various therapeutic options available, rosacea can be difficult to treat in some patients. Topical Ivermectin is approved for the treatment of rosacea. However, oral Ivermectin has not been extensively studied in the treatment of rosacea. This study aimed to (a) evaluate the efficacy, safety, adverse effects, and patient satisfaction of a single 250 µg/kg dose of oral ivermectin in the treatment of different subtypes of rosacea and (b) correlate its efficacy to different clinical variables. Also, it aimed to (c) clarify the possible role played by demodex mites in the pathogenesis of rosacea and the effect of oral Ivermectin on demodex mite count change after treatment, and its possible mechanisms in the treatment of rosacea. Methods This study included 45 rosacea patients; demodex mite count using standardized skin surface biopsies was done before and after receiving a single dose of 250 µg/kg oral Ivermectin. Disease severity was assessed at baseline and after treatment using the 5-point Global Investigator Assessment IGA scale. Patients were followed up every 4 weeks for 3 months. Results The results revealed significant Global Investigator Assessment improvement in included patients and high patient satisfaction rate. This was consistent with Demodex mites count that showed a significant decrease after treatment. A low relapse rate and few side effects were recorded. Conclusion A single 250 µg/kg dose of oral ivermectin is effective, safe, and tolerable in the treatment of different subtypes of rosacea. It exerts its action through both anti-inflammatory and antiparasitic roles.

Publisher

Medknow

Reference23 articles.

1. Update on the management of rosacea;Weinkle;Clin Cosmet Investig Dermatol,2015

2. Rosacea: New Concepts in Classification and Treatment;van Zuuren;Am J Clin Dermatol,2021

3. Standard classification and pathophysiology of rosacea;Gallo;J Am Acad Dermatol,2018

4. Topical calcineurin inhibitors as a double‐edged sword in rosacea: A systematic review;Zhang;J Cosmet Dermatol,2022

5. Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates;Chen;Biomedicines,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3